Kanamaru H, Shirahase T, Isogawa Y, Moroi S, Okuno H, Kihara Y, Kuo J Y, Taniguchi T, Arai Y
Department of Urology, Public Toyooka Hospital.
Hinyokika Kiyo. 1994 May;40(5):387-92.
We assessed the outcome of 200 patients with prostatic cancer treated at the Public Toyooka Hospital from 1980 to 1989. The patient's age varied from 53 to 94 years (mean 76.8). Overall actuarial survival rate at 5 and 10 years were 52% and 25%, respectively. The 5-year survival according to clinical stage was 69% for stage A, 66% for stage B, 43% for stage C and 32% for stage D disease. A significant difference was noted between the survival of patients with stage A or B and those with stage C or D. Patients with Gleason score of less than 7 showed significantly better survival as compared to those with Gleason score of 7 or more (5-year survival, 64% vs 33%). No significant difference was observed between the survival of patients under the age of 75 and those 75 or older.
我们评估了1980年至1989年期间在丰冈市立医院接受治疗的200例前列腺癌患者的治疗结果。患者年龄从53岁至94岁不等（平均76.8岁）。5年和10年的总体精算生存率分别为52%和25%。根据临床分期，A期疾病的5年生存率为69%，B期为66%，C期为43%，D期为32%。A期或B期患者与C期或D期患者的生存率存在显著差异。Gleason评分小于7分的患者与Gleason评分7分及以上的患者相比，生存率显著更高（5年生存率，64%对33%）。75岁以下患者与75岁及以上患者的生存率未观察到显著差异。
